Next Quarterly Earnings
Thursday, November 5, 2026
Expected
Esperion Therapeutics
Esperion Therapeutics is a US-based biopharmaceutical company specializing in the development of innovative therapies for lowering LDL cholesterol. Focusing on cardiovascular disease, the company researches and commercializes oral medications designed for patients at high risk of heart-related conditions.
Frequently asked questions
When did Esperion Therapeutics last report quarterly earnings?
Esperion Therapeutics last reported quarterly earnings on 5/7/2026 (Q1 2026). Earnings per share (EPS) came in at -0.10 USD.
How often has Esperion Therapeutics beaten expectations?
Esperion Therapeutics has beaten analyst EPS estimates in 1 of its last 4 evaluated quarters (beat rate: 25%).
How do I add the Esperion Therapeutics earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Estimates vs. results
1/4
Quarters above estimates
25%
Beat rate
-42.1%
Avg. EPS surprise
Basis: 4 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
Esperion Therapeutics
Country
🇺🇸
More Financial Information